Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LFST | PRESS-RELEASE | neutral | 4/10 | LifeStance announced a secondary offering of 35 million shares by selling stockholders, with the company concurrently re | May 7, 2026 |
| IOSP | PRESS-RELEASE | mixed | 5/10 | Innospec reported Q1 2026 adjusted non-GAAP EPS of $1.05, beating the $1.01 consensus by 4.0%, but GAAP EPS fell to $1.2 | May 7, 2026 |
| PSEC | PRESS-RELEASE | mixed | 5/10 | PSEC's Q2 fiscal 2026 earnings show a strong beat on NII per share ($0.16 vs $0.11 consensus, +45%), but total investmen | May 7, 2026 |
| IREN | PRESS-RELEASE | neutral | 5/10 | IREN acquires Spanish data center developer Nostrum Group to enter the European market and add 490MW of secured grid-con | May 7, 2026 |
| IRD | PRESS-RELEASE | bullish | 6/10 | Opus Genetics reported positive clinical data for its LCA5 gene therapy (OPGx-LCA5) showing over 30-fold improvement in | May 7, 2026 |
| DNLI | PRESS-RELEASE | bullish | 7/10 | Denali reported Q1 2026 EPS of -$0.69, a slight beat vs consensus -$0.71, but the headline is the FDA approval and U.S. | May 7, 2026 |
| SIGA | PRESS-RELEASE | bearish | 6/10 | SIGA reported Q1 2026 total revenues of $6.2M (down 11% YoY) and a net loss of $3.5M vs $0.4M loss a year ago, driven by | May 7, 2026 |
| ANNX | PRESS-RELEASE | bullish | 6/10 | Annexon reported Q1 2026 EPS of -$0.23, beating consensus of -$0.30 by 23%, with net loss narrowing to $44.1M from $54.4 | May 7, 2026 |
| SENS | PRESS-RELEASE | bullish | 7/10 | Senseonics reported Q1 2026 revenue of $11.7M (beat $9.8M consensus by 19.5%, up 87% YoY) with gross margin expanding to | May 7, 2026 |
| BBIO | PRESS-RELEASE | mixed | 6/10 | BridgeBio reported Q1 2026 revenue of $194.5M (beat $178.6M consensus) driven by $180.6M in Attruby sales, but EPS of -$ | May 7, 2026 |
| VYGR | PRESS-RELEASE | neutral | 4/10 | Voyager Therapeutics reported Q1 2026 EPS of -$0.47, beating consensus of -$0.53 by 11%, but collaboration revenue of $2 | May 7, 2026 |
| AKAM | PRESS-RELEASE | mixed | 5/10 | Akamai reported Q1 2026 revenue of $1.074B (+6% YoY) and non-GAAP EPS of $1.61, slightly above consensus of $1.60. Howev | May 7, 2026 |
| TECX | PRESS-RELEASE | neutral | 4/10 | Tectonic Therapeutic reported Q1 2026 EPS of -$1.34, a 44% wider net loss of $25.2M vs -$15.9M a year ago, driven by inc | May 7, 2026 |
| CWEN | PRESS-RELEASE | mixed | 6/10 | Clearway Energy reported Q1 2026 GAAP EPS of -$1.35, a 246% miss vs consensus of -$0.39, but revenue of $354M beat estim | May 7, 2026 |
| XENE | PRESS-RELEASE | mixed | 6/10 | Xenon Pharmaceuticals reported Q1 2026 net loss of $102.3M ($1.17/share) vs $65.0M ($0.83/share) in Q1 2025, with zero r | May 7, 2026 |
| SERV | PRESS-RELEASE | bearish | 6/10 | Serve Robotics reported Q1 2026 revenue of $3.0M (up 578% YoY, in line with consensus) but GAAP EPS of -$0.65 missed con | May 7, 2026 |
| QRHC | PRESS-RELEASE | bearish | 7/10 | Quest Resource reported Q1 2026 EPS of -$0.11, missing consensus of -$0.07 by 57%, and revenue of $61.7M, slightly below | May 7, 2026 |
| AMRX | PRESS-RELEASE | bullish | 8/10 | Amneal Pharmaceuticals reported Q1 2026 adjusted EPS of $0.27, beating consensus of $0.17 by 58.8%, and revenue of $723M | May 7, 2026 |
| CLDX | PRESS-RELEASE | mixed | 6/10 | Celldex reported Q1 2026 EPS of -$1.18 (miss vs -$1.13 consensus) and revenue of $15K (miss vs $861K), reflecting wideni | May 7, 2026 |
| BJDX | PRESS-RELEASE | neutral | 2/10 | Bluejay Diagnostics provided a Q1 2026 corporate update highlighting continued enrollment in its SYMON-II pivotal study | May 7, 2026 |
| PROP | PRESS-RELEASE | neutral | 2/10 | Prairie Operating Co. announced it will release Q1 2026 financial results after market close on May 14, 2026, followed b | May 7, 2026 |
| INMB | PRESS-RELEASE | mixed | 4/10 | INmune Bio reported Q1 2026 net loss narrowed to $5.4M from $9.7M YoY, but EPS of -$0.20 missed consensus of -$0.18 by 1 | May 7, 2026 |
| ASMB | PRESS-RELEASE | bullish | 6/10 | Assembly Biosciences reported Q1 2026 EPS of -$0.54, beating consensus of -$0.73 by 26%, while collaboration revenue fro | May 7, 2026 |
| EPOW | PRESS-RELEASE | neutral | 3/10 | E-Power announced a Chinese patent grant for a double-layer coated silicon-carbon composite material aimed at solid-stat | May 7, 2026 |
| FTS | PRESS-RELEASE | neutral | 2/10 | Fortis Inc. announced the voting results from its Annual Meeting of Shareholders. All director nominees were elected, De | May 7, 2026 |
| LMND | PRESS-RELEASE | neutral | 2/10 | Lemonade announced the launch of its renters insurance product in West Virginia, expanding its digital insurance platfor | May 7, 2026 |
| HOV | PRESS-RELEASE | neutral | 1/10 | Hovnanian Enterprises, Inc. announced it will report its fiscal Q2 2026 results on May 21, 2026. | May 7, 2026 |
| APCXW | PRESS-RELEASE | neutral | 2/10 | AppTech Payments announced that Albert L. Lord, previously Chairman, will assume the role of Executive Chairman, expandi | May 7, 2026 |
| GFS | PRESS-RELEASE | bullish | 6/10 | GlobalFoundries announced its first-ever quarterly dividend of $0.12 per share and a new capital allocation framework ta | May 7, 2026 |
| TMC | PRESS-RELEASE | neutral | 1/10 | The Metals Company announced it will host a conference call on May 14, 2026 to discuss its Q1 2026 results. | May 7, 2026 |